MissionIR's  Instablog

Send Message
We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices. It is our unwavering commitment to connect the investment community with companies that have great potential and a strong dedication to... More
My company:
My blog:
MissionIR Blog
  • BioTime Inc. (BTX) Subsidiary Receives $10 Million in Equity Financing 0 comments
    Aug 24, 2011 1:40 PM | about stocks: BTX
    BioTime Inc. is a biotechnology company that, through various subsidiaries, develops and markets products in the field of regenerative medicine and blood plasma volume expanders.
    The company announced today that one of its majority-owned subsidiaries, OncoCyte Corporation, has received a new round of equity financing to fund the expansion of its development of novel proprietary diagnostics and therapeutics for cancer in humans. The financing includes $4 million in cash ($3 million from an outside investor) combined with $6 million worth of BioTime common shares.
    OncoCyte’s products for the diagnosis and treatment of cancer are based on embryonic stem cell-derived technology. Its molecular diagnostics division is developing products that may provide for earlier detection and more effective treatment of various cancers. Utilizing its proprietary algorithms, OncoCyte has currently discovered and filed patent applications on over 100 novel cancer-associated genes. The company expects to use its new financing to expand its current patent portfolio and to advance the development and commercialization of any resulting new diagnostic and therapeutic products.
    This is truly a rapid growth field. The total market for next generation cancer diagnostics is believed to be growing at a rate of 47 percent annually, with a forecast global market size of over $5 billion by 2015. The overall cancer therapeutic market was reported to be over $50 billion worldwide in 2010 and represents the most rapidly growing segment of the pharmaceutical industry.
    For further information on BioTime, OncoCyte and BioTime’s other subsidiaries, please visit the company’s website at biotimeinc.com
    Please see disclaimer on the MissionIR website www.missionir.com/disclaimer.html 
    Stocks: BTX
Back To MissionIR's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.